Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intra-gastric balloon for weight loss, announces that Bill Plovanic, President and Chief Executive Officer, will present corporate overviews at the following investor conferences:

Stifel 2019 Healthcare Conference                                                                                

Wednesday, November 20, 2019, Presentation time 9:10am ET                      Lotte New York Palace Hotel, New York City                                                                                                          Webcast Available at: http://wsw.com/webcast/stifel18/obln/

Canaccord Genuity Medical Technologies & Diagnostics Forum

Thursday, November 21, 2019, Presentation time 2:00pm ET                                                            The Westin Grand Central Hotel, New York City                                                                                                           Webcast Available at: http://wsw.com/webcast/canaccord37/obln/

Live audio webcasts of the presentation can be accessed through the links above. Replays of the webcasts will be available for 90 days following each presentation.

About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. For more information, please visit www.obalon.com.

For Obalon Therapeutics, Inc.

Investor Contact: Bill Plovanic President & Chief Executive Officer Obalon Therapeutics, Inc. Office: +1 760 607 5103 wplovanic@obalon.com

 

Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Obalon Therapeutics Charts.
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Obalon Therapeutics Charts.